Vascular Protection by Ketanserin, a 5-HT2 Serotonergic Receptor Antagonist?: Platelets: Vol 2, No 3

Views

CrossRef citations to date

Altmetric

Abstract

Based upon experimental data, we advance the hypothesis that ketanserin, a 5-HT₂ serotonergic receptor antagonist, may provide protection against pathologies resulting from platelet-vessel wall interactions such as myointimal proliferation, vasospasms and thrombus formation. Clinical data support the possibility that such a vascular protection is operational also in man.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Vascular Protection by Ketanserin, a 5-HT₂ Serotonergic Receptor Antagonist?

Information for

Open access

Opportunities

Help and information

Vascular Protection by Ketanserin, a 5-HT2 Serotonergic Receptor Antagonist?

Abstract

Reprints and Corporate Permissions

Academic Permissions

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date

Your download is now in progress and you may close this window

Login or register to access this feature

Vascular Protection by Ketanserin, a 5-HT₂ Serotonergic Receptor Antagonist?